Health News
Stay informed with the latest health industry news from around the globe. Read about advancements in health technology, updates in health insurance, innovations in medical devices, and more. Keep up with important health trends and industry developments.
May 2, 2025 at 6:30 AM
Butterfly Network Reports First Quarter 2025 Financial Results
BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) (“Butterfly” or the “Company”), a digital health company transforming care with portable, semiconductor-based ultrasound technology and intuitive software, today announced financial results for the first quarter ended March 31, 2025, and provided a business update. Joseph DeVivo, Butterfly's President, Chief Executive Officer and Chairman commented, “2025 is off to a great start. The Butterfly team hit the mark...
May 2, 2025 at 6:00 AM
Exact Sciences to Participate in May Investor Conference
MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. BofA Securities Health Care Conference, Las Vegas Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT) The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.co...
May 2, 2025 at 6:00 AM
Amneal Reports First Quarter 2025 Financial Results
BRIDGEWATER, N.J.--(BUSINESS WIRE)--AMNEAL REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS...
May 1, 2025 at 8:55 PM
InnoCare’s Zurletrectinib Receives Priority Review from China’s NMPA
BEIJING--(BUSINESS WIRE)--InnoCare Pharma (HKEX: 09969), a leading biopharmaceutical company for the treatment of cancer and autoimmune diseases, announced today that its new generation pan-TRK inhibitor zurletrectinib (ICP-723) has been granted priority review by the Center for Drug Evaluation (CDE) of the China National Medical Products Administration (NMPA), which accepted the New Drug Application (NDA) of zurletrectinib for the treatment of patients with advanced solid tumors harboring NTRK...
May 1, 2025 at 8:24 PM
Genmab to Submit Supplemental Biologics License Application (sBLA) to U.S. Food and Drug Administration for Epcoritamab Plus Rituximab and Lenalidomide (R2) in Patients with Relapsed/Refractory Follicular Lymphoma (FL)
COPENHAGEN, Denmark--(BUSINESS WIRE)--Genmab A/S (Nasdaq: GMAB) announced today its intention to submit in the first half of 2025 a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for subcutaneous epcoritamab, a bispecific antibody being investigated in combination with rituximab and lenalidomide (R2) for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma (FL), following at least one prior systemic therapy. The...
May 1, 2025 at 7:25 PM
Autism Care Improves With Team-Based Caregiver Training, ACES Finds
IRVINE, Calif.--(BUSINESS WIRE)--Children with autism have measurably better outcomes when their caregivers participate in team-based training, according to a report released today by ACES 2020, LLC (“ACES”), the country’s leading provider of services to people with autism and other special needs. “The reality that caregivers are vital to their child’s outcomes has been well documented in ABA research for the last few decades. Our study showed that outcomes also are influenced by the type of tr...
May 1, 2025 at 6:28 PM
LifeCare Solutions and PATHS Partner to Deliver Scalable Dementia Caregiver Support for CMS GUIDE Model Success
AUBURN, Ala.--(BUSINESS WIRE)--LifeCare Solutions for Seniors, LLC (LifeCare Solutions), a leader in care management for individuals with complex health needs, today announced a strategic partnership with PATHS, the patient engagement and education platform redefining connected care journeys. Together, they are launching a scalable solution to deliver expert dementia care support as part of the Centers for Medicare & Medicaid Services’ (CMS) Guiding an Improved Dementia Experience (GUIDE) M...
May 1, 2025 at 5:49 PM
Árpád Széchényi Joins Pharmachem Innovations as President and CEO
KEARNY, N.J.--(BUSINESS WIRE)--Pharmachem Innovations is pleased to announce the appointment of Árpád Széchényi as President and CEO. Mr. Széchényi is an accomplished senior executive with a track record of success in the pharmaceutical and consulting industries. Most recently, Mr. Széchényi served as President of Landsman Pharma, a professional services company. Before joining Landsman Pharma, Mr. Széchényi held executive positions at Epic Pharma, PuraCap International, VistaPharm LLC, and San...
May 1, 2025 at 5:20 PM
Cutera® Successfully Completes Restructuring Transaction and Moves Forward with Enhanced Capital Structure
BRISBANE, Calif.--(BUSINESS WIRE)--CUTERA, INC., (“Cutera” or “the Company”), a leading provider of aesthetic and dermatology solutions, today announced that the Company has successfully completed its financial restructuring process and emerged from Chapter 11. Cutera emerges with a significantly stronger balance sheet, well positioned to drive innovation and growth. Through this process, Cutera has reduced its debt by nearly $400 million, or over 90%, and raised $65 million in new money financ...
May 1, 2025 at 4:39 PM
Truss Peak Holdings Announces Acquisition of Leaders Life Insurance Company
TULSA, Okla. & CHARLOTTE, N.C.--(BUSINESS WIRE)--Truss Peak Holdings LLC, through its subsidiary, TPH Insurance Hold Co LP (“Truss Peak”), today announced it has closed its acquisition of Leaders Life Insurance Company (“Leaders”), a Tulsa-based provider of life and health insurance products. Michigan Farm Bureau Financial Corporation previously owned Leaders Life Insurance Company. Founded in 1989, Leaders is licensed in 15 states and currently serves customers through worksite-based distribut...
Media & Journalist Tools
From headlines to storylines—Business Wire delivers the news you need, when you need it.